We are live on ! Find out more
EAM

Exome Asset Management Portfolio holdings

AUM $193M
1-Year Est. Return 208.51%
This Fund
S&P 500
This Quarter Est. Return
+43.4%
1 Year Est. Return
+208.51%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$101M
AUM Growth
–
Cap. Flow
+$84.4M
Cap. Flow %
83.47%
Top 10 Hldgs %
42.21%
Holding
52
New
52
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$6.02M
2
LLY icon
Eli Lilly
LLY
+$5.66M
3
CI icon
Cigna
CI
+$4.47M
4
GPCR icon
Structure Therapeutics
GPCR
+$3.9M
5
IMGN
Immunogen Inc
IMGN
+$3.72M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGLS
51
DELISTED
Regulus Therapeutics
RGLS
$228K 0.23%
+178,404
New +$238K
KNTE
52
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$199K 0.2%
+83,848
New +$148K
1 2
3

Similar funds

WWC
Waypoint Wealth Counsel Atlanta, Georgia $193M AUM 30.17% 1-Year Est. Return
JHA
Jackson Hill Advisors Houston, Texas $193M AUM 4.94% 1-Year Est. Return
TDWM
Topel & Distasi Wealth Management Berkeley, California $193M AUM 12.07% 1-Year Est. Return
DF
Downshift Financial Boulder, Colorado $193M AUM
SCM
Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return
PA
Promethium Advisors Bethesda, Maryland $193M AUM 23.69% 1-Year Est. Return
SCPM
Sea Cliff Partners Management San Francisco, California $194M AUM 8.22% 1-Year Est. Return
CA
Carson Advisory Athens, Georgia $193M AUM 14.52% 1-Year Est. Return

Exome Asset Management's Q4 2023 Portfolio in Review

Q4 2023 is the first quarter with a 13F filing on record for Exome Asset Management, which disclosed 52 positions worth $101M. Its ten largest holdings account for 42% of the portfolio.

Its largest position is Dr. Reddy's Laboratories: 450,000 shares worth $6.26M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Exome Asset Management's largest Q4 2023 buy was Dr. Reddy's Laboratories: 450,000 shares worth $6.26M.
  • Exome Asset Management's ten largest holdings make up 42% of its $101M portfolio in Q4 2023.
  • Exome Asset Management disclosed 52 positions in Q4 2023, its first 13F filing on record.

Based on Exome Asset Management's 13F filing for Q4 2023, filed 15 Feb 2024.